CME Group Inc.

Informe acción NasdaqGS:CME

Capitalización de mercado: US$75.9b

CME Group Crecimiento futuro

Future controles de criterios 1/6

Se prevé un crecimiento anual de los beneficios y los ingresos de CME Group de 3.4% y 4.3% por año respectivamente. Se prevé que el BPA crezca en un 3.5% al año. Se espera que la rentabilidad financiera sea de 13.3% en 3 años.

Información clave

3.4%

Tasa de crecimiento de los beneficios

3.4%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Capital Markets15.7%
Tasa de crecimiento de los ingresos4.3%
Rentabilidad financiera futura12.9%
Cobertura de analistas

Good

Última actualización26 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results

Apr 26
Analysts Are Updating Their CME Group Inc. (NASDAQ:CME) Estimates After Its First-Quarter Results

CME Group: Appealing Business Characteristics That Could Benefit From Geopolitical Uncertainty

Apr 15

CME Group: Improved Valuation Offset By Low Market Volatility And Higher Rates

Mar 27

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

Mar 05
CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

CME Group Is One Of My Favorite High-Yielding Stocks Today

Feb 29

CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15

Feb 20
CME Group (NASDAQ:CME) Has Announced A Dividend Of $1.15

CME Group: Buying 'The House' Proves A Winning Strategy

Feb 14

CME Group: Uncertainty In The World Equals Higher Revenue Growth

Feb 04

Getting In Cheap On CME Group Inc. (NASDAQ:CME) Is Unlikely

Dec 27
Getting In Cheap On CME Group Inc. (NASDAQ:CME) Is Unlikely

Here's Why CME Group (NASDAQ:CME) Has Caught The Eye Of Investors

Nov 14
Here's Why CME Group (NASDAQ:CME) Has Caught The Eye Of Investors

We Think Some Shareholders May Hesitate To Increase CME Group Inc.'s (NASDAQ:CME) CEO Compensation

Apr 28
We Think Some Shareholders May Hesitate To Increase CME Group Inc.'s (NASDAQ:CME) CEO Compensation

CME Group (NASDAQ:CME) Is Paying Out A Larger Dividend Than Last Year

Dec 15
CME Group (NASDAQ:CME) Is Paying Out A Larger Dividend Than Last Year

CME Group ADV climbs 21% Y/Y to 6.1M in Q3

Oct 11

CME Group Is The Perfect Dividend Stock To Buy While It's Cheap

Sep 30

CME Group launches ethereum options ahead of this week's blockchain Merge

Sep 12

With EPS Growth And More, CME Group (NASDAQ:CME) Makes An Interesting Case

Sep 08
With EPS Growth And More, CME Group (NASDAQ:CME) Makes An Interesting Case

CME Group proposes converting eurodollar futures, options contracts to SOFR

Sep 06

CME Group launches bitcoin Euro and ether Euro futures

Aug 29

CME Group set to launch ether futures options in September

Aug 18

CME Group ADV perks up 20% in July in wake of volatile markets

Aug 02

CME Q2 2022 Earnings Preview

Jul 26

CME achieves 21% growth in Q2 international ADV

Jul 12

CME Group average daily volume jumps to 24M contracts in June

Jul 05

CME Nears A Do-Or-Die Moment

May 27

Why CME Should Be In Our Dividend Growth Portfolios

Apr 30

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:CME - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20266,4923,6533,984N/A8
12/31/20256,1333,4873,773N/A14
12/31/20245,9193,4483,745N/A14
3/31/20245,6153,157N/AN/AN/A
12/31/20235,5693,1863,3773,454N/A
9/30/20235,3383,0113,3113,391N/A
6/30/20235,2282,9423,1083,192N/A
3/31/20235,1042,8283,0783,159N/A
12/31/20225,0092,6572,9663,056N/A
9/30/20224,8332,6332,6502,743N/A
6/30/20224,7152,8892,6162,717N/A
3/31/20224,6572,7452,4772,599N/A
12/31/20214,6902,6172,2752,402N/A
9/30/20214,6302,4352,2252,394N/A
6/30/20214,6001,9201,8882,074N/A
3/31/20214,6031,9132,3782,561N/A
12/31/20204,8842,1052,5182,716N/A
9/30/20204,9112,1512,5812,775N/A
6/30/20205,1092,3753,0713,274N/A
3/31/20205,2002,3862,5212,761N/A
12/31/20194,8682,1172,4272,673N/A
9/30/20194,9592,0332,2292,464N/A
6/30/20194,5881,8082,0272,236N/A
3/31/20194,3771,8602,1372,285N/A
12/31/20184,3091,9622,3242,441N/A
9/30/20183,9734,5162,3012,391N/A
6/30/20183,9594,4132,2422,316N/A
3/31/20183,8244,2621,9772,057N/A
12/31/20173,6454,063N/A1,751N/A
9/30/20173,6581,498N/A1,801N/A
6/30/20173,6091,662N/A1,773N/A
3/31/20173,5901,566N/A1,732N/A
12/31/20163,5951,534N/A1,732N/A
9/30/20163,4961,452N/A1,607N/A
6/30/20163,5051,340N/A1,591N/A
3/31/20163,4181,284N/A1,626N/A
12/31/20153,3271,247N/A1,533N/A
9/30/20153,3541,262N/A1,644N/A
6/30/20153,2661,192N/A1,414N/A
3/31/20153,1781,191N/A1,327N/A
12/31/20143,1131,127N/A1,291N/A
9/30/20142,9581,014N/A1,171N/A
6/30/20142,911960N/A1,066N/A
3/31/20142,9901,008N/A1,268N/A
12/31/20132,931977N/A1,281N/A
9/30/20132,905951N/A1,221N/A
6/30/20132,874932N/A1,331N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (3.6% al año) de CME es superior a la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (3.4% al año) de CME crezcan menos que el mercado US (14.4% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de CME crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (4.3% al año) de CME crezcan más despacio que el mercado de US (7.9% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 4.3% al año) de CME crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de CME sea baja dentro de 3 años (13.3%).


Descubre empresas en crecimiento

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target